Nuvation has a best-in-class lung cancer drug that could be approved in the US in June. Read why I'm bullish on the stock ...
Cancer researcher Karen Sfanos says she is 'terrified' of the impact of NIH funding cuts that support vital biomedical research across the U.S.
Finding a clinical trial that is a good fit can be challenging. Here's how to get the most out of your clinical trial search.
There is currently no drug approved worldwide for the treatment of sudden hearing loss. However, preclinical and clinical ...
Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, expectations were $-1.07. Operator: Good day, and thank you for standing by.
10h
Ledger-Enquirer on MSNHealth Care News: Centricity Research expands footprint in Columbus, GACentricity Research celebrated the opening of its new clinical research facility at 910 Talbotton Rd. in Columbus, Georgia on ...
Efforts by the Trump administration to drastically cut federal investments in medical research are threatening to kneecap ...
Results of a placebo-controlled trial support prior observational findings that GLP-1 agonists can help reduce alcohol ...
The E.mbrace study is a randomized, double-blind, placebo-controlled, multicenter, interventional phase 3 study evaluating the efficacy, safety, and immunogenicity of a single dose of the vaccine ...
Alphamab Oncology (stock code: 9966.HK) announced that the first patient has been successfully dosed in the Phase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results